🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK NHS GLP-1 prescribing — what worked for you? Page 2

UK NHS GLP-1 prescribing — what worked for you?

kevin_tulsa Fri, Apr 10, 2026 at 12:49 AM 13 replies 633 viewsPage 2 of 3
patPC_UT
Member
212
890
Nov 2024
Park City, UT
Apr 10, 2026 at 3:39 AM#6

Just to add the Wales perspective — we're on a completely different system. Welsh Government commissioned a separate review and semaglutide for obesity is not yet approved by AWMSG (All Wales Medicines Strategy Group). Our Tier 3 services don't prescribe it at all currently.

Scotland is ahead of England actually — the SMC approved it in 2024 and some NHS boards are already prescribing through their weight management pathways with waits of 4-6 months.

Devolution means four completely different systems for the same drug. Madness.

8 12sarah_nash92, FitDadDave, RunnerRach and 5 others
Reply Quote Save Share Report
rick_sfbay
Member
289
1,234
Jan 2025
San Francisco, CA
Apr 10, 2026 at 3:56 AM#7

One more thing — check if your area has the NHS Wegovy pilot programme. It launched in parts of London, Manchester, and the Midlands in late 2025. Patients in the pilot get fast-tracked (2-4 week wait) and get free behavioural support alongside the medication.

I don't think Leeds is in the pilot yet, but it's expanding. Novo Nordisk is partly funding it as a real-world evidence study.

9 4NicoleRaleigh, james_edin, FranDenver and 6 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Apr 10, 2026 at 4:13 AM#8

This is all incredibly helpful. I'm going to:

  1. Check the pilot programme — fingers crossed
  2. Book a private endocrinologist consultation and try the shared-care route mentioned
  3. Keep the Tier 3 referral active as a backup

The idea that I have to wait 16 months with a BMI of 38, diabetes, and hypertension while the drug is literally approved and sitting in pharmacies is just absurd. But at least there are workarounds. Will update the thread.

3 18wanda_boise, NurseAsh_DET, BenResearch_OR
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register